금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Australian Dollar pulls back as inflation expectations loom
The Aussie Dollar ended Wednesday’s session with losses against the Greenback as US inflation data m...
Euro reverses from two-day high, fade US soft CPI move
The Euro reversed course after reaching a two-day high of 1.1563, following the release of a benign ...
ChoiceOne Financial Announces Cash Dividends
ChoiceOne Financial Services, Inc. announced today that its Board of Directors has declared a cash dividend on the Corporation's common stock of $0.29 per share. The cash dividend is payable to shareh ...
US Equity Indexes Jump Ahead of Nvidia's Quarterly Results
US equity indexes jumped ahead of Nvidia's (NVDA) earnings and as government bond yields sank amid a
Vanguard’s $94 Billion Mid Cap ETF Is Quietly Beating the S&P 500 With a Fifty Year Old Strategy
Most retirees who own an S&P 500 index fund hold a portfolio dominated by mega-cap technology, with mid-sized businesses getting almost no weight despite making up a meaningful share of corporate Amer ...
ProShares Equities for Rising Rates ETF reaches another all-time high
Leading AI chatbots produce inaccurate or biased results 90% of time on election topics: study
Super Hi outlines store expansion discipline while reporting Q1 revenue of RMB 226M
Vanguard S&P 500 ETF (VOO): Graham Stephan Likes This Index Fund
We just covered the Graham Stephan Stock Portfolio: Top 11 Stocks and Vanguard S&P 500 ETF (NYSE:VOO) ranks 7th on this list. Vanguard S&P 500 ETF (NYSE:VOO) is another index fund that Graham Stephan ...
Midwest listings site suspends its data feed to Zillow
Vanguard 500 Index Fund (VFIAX): Top Stock Pick by Graham Stephan
We just covered the Graham Stephan Stock Portfolio: Top 11 Stocks and Vanguard 500 Index Fund (NASDAQ:VFIAX) ranks 6th on this list. Vanguard 500 Index Fund (NASDAQ:VFIAX) is an index fund that Graham ...
Monashee Scales Back Its Bet on Structure Therapeutics
This clinical-stage biotech develops oral therapies for chronic diseases, with a lead candidate targeting type-2 diabetes and obesity.
Traders bet big on OpenAI beating Anthropic to IPO first
These 2 AI Giants Have Been Dormant. That’s Exactly Why They Might Surprise Investors
The AI trade has had favorites. NVIDIA, Microsoft, Alphabet, and Meta have carried the narrative, while two enterprise tech giants have quietly compounded earnings and built backlogs that few retail i ...